Alkem Labs up 6% on Q4 beat; early Tolvaptan launch, tax cut cheer Street

In the March quarter, Alkem Laboratories reported a fall in consolidated net profit by 22.7 per cent year-on-year (Y-o-Y) for the fourth quarter (Q4) of the financial year 2025-26 (FY26) to ₹236 crore

Go to News Site